IPO Five Prime Therapeutics (FPRX) is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics. Protein therapeutics are antibodies or drugs that block disease processes, including cancer and inflammatory diseases. Five Prime has developed a library of more than 5,600 human extracellular proteins, and use their proprietary screening technologies to identify new targets for protein therapeutics.
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
No comments:
Post a Comment